Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 5: Chronic Lymphocytic Leukemia and Lymphomas

Research To Practice | Oncology Videos

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in chronic lymphocytic leukemia and lymphomas. Featuring perspectives from Drs Brad Kahl and Andrew Zelenetz, including the following topics:

• Introduction
• Case: A man in his early 70s with relapsed mantle cell lymphoma — Zanetta S Lamar, MD
• Chimeric Antigen-Receptor (CAR) T-Cell Therapy and Use in Elderly Patients — Dr Gandhi
• Optimal Second-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) After R-CHOP Chalk Talk — Dr Zelenetz
• Sequencing Tafasitamab/Lenalidomide with Other Novel Agents for Relapsed/Refractory (R/R) DLBCL Chalk Talk — Dr Kahl
• Case: A woman in her early 20s with mixed cellularity classical Hodgkin lymphoma — Dr Peles
• Hodgkin Lymphoma Chalk Talk — Dr Kahl
• Treatment of p53-Negative versus p53-Positive Disease — Dr Kumar
• Selection of Front-Line BTK Inhibitors for Patients with Chronic Lymphocytic Leukemia Chalk Talk — Dr Zelenetz
• Combining Venetoclax with an Anti-CD20 Antibody for Relapsed Chronic Lymphocytic Leukemia Chalk Talk — Dr Kahl
• Case: A man in his early 80s with Grade I-II follicular lymphoma — Dr Shameem
• Treatment Options for Relapsed Follicular Lymphoma — Dr Peles
• Role of Tazemetostat in Therapy for Relapsed Follicular Lymphoma with and without an EZH2 Mutation Chalk Talk — Dr Zelenetz

CME information and select publications